Log in
Registration
Українська
English
Search for:
Home
Online Publication
Current Issue
Issue Archive
Authors
About
Information About the Journal
Focus and Scope
Indexing
For Authors
Submission Guidelines and Requirements
Peer Review
Article Processing Charges
Copyright and Licensing
Policies
Editorial Policy
Plagiarism Policy
Archiving Policy
Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies
Open Access
Procedure for the Retraction of Published Articles
Ethical Issues
Publication Ethics
Procedure for Handling Complaints Regarding Ethical Breaches
Privacy Statement
International Standards and Principles of Operation
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Rubric : Tumors of the chest cavity
The role of T790M mutation in first- and second-line therapy of patients with EGFR-positive non-small cell lung cancer
Authors: Storozhenko S.A. Shparyk Ya.V. Т. 13, № 1 (49)
Ki-67 expression rates as indicator of metastatic lesions in lung neuroendocrine neoplasms
Author:Chytaieva H. Т. 12, № 3-4 (47-48)
Efficacy of EGFR TKIs of different generations in NSCLC with EGFR mutations: review of clinical studies and our experience
Authors: Kobziev O.I. Boiarskyi O.O. Leonova V.V. Т. 12, № 3-4 (47-48)
Modern treatment approaches of patients with NSCLC and «rare» EGFR mutations and own experience in the treatment of patients with an insertion in the 20th exon
Т. 12, № 3-4 (47-48)
The detection of tumor cells in the unchanged parenchyma — is a reliable sign of the spread of lung cancer
Authors: Bolhova L. Ponomarenko A. Hanul V. Т. 12, № 3-4 (47-48)
TOP2A expression as the essential prognostic factor in lung neuroendocrine tumors
Authors: Chytaieva H.E. Zakhartseva L.M. Т. 11, № 3-4 (43-44)
Possibilities of exfoliative cytological diagnostics depending on the growth pattern of lung cancer
Authors: Bolgova L.S. Tuganova T.N. Alekseenko O.I. Yaroschuk T.M.... Т. 11, № 3-4 (43-44)
Successful treatment of multiple complications after pancreatoduodenectomy
Authors: Mushenko E.V. Tyshchenko O.M. Smachylo R.M. Starenkiy V.P.... Т. 11, № 3-4 (43-44)
World Conference on Lung Cancer 2020: new in the treatment of advanced/metastatic NSCLC
Т. 11, № 1-2 (41-42)
HIPEC in combined treatment of intraperitoneally disseminated cancer: a monocentric experience of 215 operations
Authors: Yarema R.R. Fetsych Т.G. Ohorchak М.А. Volodko N.A.... Т. 11, № 1-2 (41-42)
Five-year overall survival and progression-free survival of patients with advanced NSCLC receiving pembrolizumab
T. 10, № 3-4 (39-40)
Analysis of mortality of patients with colorectal cancer in Kharkiv’s multidisciplinary hospitals
Authors: Yakovtsova I.I. Yakimenko A.S. Ivakhno I.V. Danyliuk S.V.... T. 10, № 3-4 (39-40)
Divertive ileostomy in left-sided colorectal resections: retrospective analysis and literature review
Authors: Skoryi D. Ilin I. Trehub Y. T. 10, № 3-4 (39-40)
Pembrolizumab is first-line treatment for patients with advanced non-small cell lung cancer in both mono and combination regimens
T. 10, № 1-2 (37-38)
Prevalence of
EGFR
gene mutations in Ukrainian patients with locally advanced or metastatic non-small cell lung cancer
Authors: Shparyk Ya.V. Ponomareva O.V. Sokolov V.V. Kobzev O.Y.... T. 10, № 1-2 (37-38)
1
2
3
4
»